Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection

Autor: Baerbel S. Blaum, Holger Hengel, Rachel M. Schowalter, Warren W. Wakarchuk, Makoto Kiso, Hiromune Ando, Christopher B. Buck, Ursula Neu, Dennis Macejak, Thomas Peters, Niklas Arnberg, Robert L. Garcea, Thilo Stehle, Akihiro Imamura, Michel Gilbert
Rok vydání: 2012
Předmět:
Models
Molecular

crystallization
Protein Conformation
Glycobiology
Merkel cell polyomavirus
Oligosaccharides
virus entry
medicine.disease_cause
Crystallography
X-Ray

n acetylneuraminic acid
Biochemistry
polyomavirus infection
chemistry.chemical_compound
protein purification
Emerging Viral Diseases
Biomacromolecule-Ligand Interactions
lcsh:QH301-705.5
Glycosaminoglycans
0303 health sciences
biology
Merkel cell carcinoma
virus mutation
Antivirals
capsid protein
3. Good health
Oncology
sialic acid
Receptors
Virus

Medicine
Oncology Agents
virus morphology
Polyomavirus
mutagenesis
Research Article
virus DNA
lcsh:Immunologic diseases. Allergy
Glycan
Viral protein
ligand binding
Immunology
Virus Attachment
Sialic acid binding
Viral Structure
chemistry
Microbiology
virus receptor
Microbiology in the medical area
Cell Line
VP1 protein
polyomavirus

03 medical and health sciences
complex formation
Virology
glycosaminoglycan
Genetics
medicine
Mikrobiologi inom det medicinska området
oligosaccharide
Humans
protein structure
protein expression
Molecular Biology
Biology
030304 developmental biology
Polyomavirus Infections
Binding Sites
binding site
030306 microbiology
Proteins
cell adhesion
nucleotide sequence
X ray crystallography
Virus Internalization
biology.organism_classification
medicine.disease
N-Acetylneuraminic Acid
Sialic acid
carbohydrates (lipids)
Epitope mapping
lcsh:Biology (General)
Viruses and Cancer
physiology
DNA
Viral

Mutation
chemical structure
biology.protein
Parasitology
Capsid Proteins
Miridae
protein VP1
lcsh:RC581-607
metabolism
N-Acetylneuraminic acid
Epitope Mapping
Zdroj: PLoS Pathogens
PLoS Pathogens, Vol 8, Iss 7, p e1002738 (2012)
ISSN: 1553-7374
Popis: The recently discovered human Merkel cell polyomavirus (MCPyV or MCV) causes the aggressive Merkel cell carcinoma (MCC) in the skin of immunocompromised individuals. Conflicting reports suggest that cellular glycans containing sialic acid (Neu5Ac) may play a role in MCPyV infectious entry. To address this question, we solved X-ray structures of the MCPyV major capsid protein VP1 both alone and in complex with several sialylated oligosaccharides. A shallow binding site on the apical surface of the VP1 capsomer recognizes the disaccharide Neu5Ac-α2,3-Gal through a complex network of interactions. MCPyV engages Neu5Ac in an orientation and with contacts that differ markedly from those observed in other polyomavirus complexes with sialylated receptors. Mutations in the Neu5Ac binding site abolish MCPyV infection, highlighting the relevance of the Neu5Ac interaction for MCPyV entry. Our study thus provides a powerful platform for the development of MCPyV-specific vaccines and antivirals. Interestingly, engagement of sialic acid does not interfere with initial attachment of MCPyV to cells, consistent with a previous proposal that attachment is mediated by a class of non-sialylated carbohydrates called glycosaminoglycans. Our results therefore suggest a model in which sialylated glycans serve as secondary, post-attachment co-receptors during MCPyV infectious entry. Since cell-surface glycans typically serve as primary attachment receptors for many viruses, we identify here a new role for glycans in mediating, and perhaps even modulating, post-attachment entry processes.
Author Summary Viruses must interact with specific receptor molecules on their host cells in order to first attach to the cell and second gain entry into it. Therefore, a viral entry pathway is a sequence of precisely regulated binding events between viral proteins and their cellular receptors, which can be proteins or other biomolecules. In the present study, we investigated the human Merkel cell polyomavirus (MCPyV or MCV) and show that it uses complex carbohydrates containing sialic acid as receptors for entry. MCPyV was discovered in 2008, is widespread in humans and can cause aggressive skin tumors termed Merkel cell carcinomas in immunosuppressed individuals. We determined the crystal structures of the MCPyV capsid protein bound to sialylated carbohydrates, describing the contacts needed for receptor recognition in molecular detail. When we introduced targeted mutations that abolished sialic acid binding into the virus, it was unable to infect cells although it could still attach to them. Earlier studies showed that the virus uses a different group of carbohydrates called glycosaminoglycans for initial attachment to the cell surface. Thus, its entry pathway involves sequential binding to two distinct classes of carbohydrates. Our structures can be used as a starting point to develop antivirals against MCPyV.
Databáze: OpenAIRE